The genome of the influenza A virus is composed of eight single-stranded 21 negative-sense RNA segments (vRNAs). The eight different vRNAs are 22 6 are arranged in a specific '1+7' pattern, where one vRNP is surrounded by 56 the other seven vRNPs [3, 4]. The mechanism by which each copy of the 57 eight vRNAs is selected from a large pool of vRNAs and non-viral RNAs in 58 virus-infected cells, and how these vRNAs are organized into the specific 59 '1+7' arrangement, remains unclear. The segment-specific packaging signal 60 sequences, located in the noncoding and terminal coding regions of both 61 the 3' and 5' ends of each vRNA, likely ensure the integrity of genome 62 packaging [5][6][7][8][9][10]. The terminal coding regions within these packaging signal 63 sequences are thought to be involved in co-packaging of multiple vRNAs, 64
selectively packaged into progeny virions. This process likely involves 23 specific interactions among vRNAs via segment-specific packaging signals 24 located in the 3' and 5' terminal coding regions of vRNAs. To identify 25 vRNA(s) that interact with hemagglutinin (HA) vRNA during genome 26 packaging, we generated a mutant virus, HA 5m2, which possessed five 27 silent mutations in the 5' packaging signal region of HA vRNA. The HA 5m2 28 virus had a specific defect in HA vRNA incorporation, which reduced the 29 viral replication efficiency. After serial passaging in cells, the virus acquired 30 additional mutations in the 5' terminal packaging signal regions of both HA 31 and PB2 vRNAs. These mutations contributed to recovery of viral growth 32 and packaging efficiency of HA vRNA. A direct RNA-RNA interaction 33 between the 5' ends of HA and PB2 vRNAs was confirmed in vitro. Our interactions in the context of vRNPs have shown that the NPs bind to vRNA 49 nucleotides non-uniformly without sequence specificity[1, 2], suggesting 50 that some parts of the vRNAs are free of NPs, and can potentially form 51 secondary or tertiary structures that protrude from the surface of rod-52 shaped vRNPs. 53
There is evidence to suggest that progeny virions selectively 54 package each copy of the eight vRNAs. In virions, the eight different vRNPs 55 7 To further examine the likely involvement of vRNA-vRNA 73 interactions in genome packaging, it is necessary to identify which vRNA 74 segments interact with one another, and which regions of each vRNA 75 segment participate in these interactions. The potential in-vitro interactions 76 of various naked vRNA segments have previously been described in human 77 H3N2 and avian H5N2 viruses [22, 24] . However, the various combinations 78 of vRNA-vRNA interactions differ between the two viruses. It also remains 79 unclear whether such in-vitro vRNA-vRNA interactions in the absence of 80 NPs reflect interactions that may occur among vRNPs in vivo. Only some 81 nucleotides that are important for vRNA-vRNA interactions have been 82 identified in the context of virus replication in cells and co-packaging into 83 virions [22, 25] . These studies suggest that the 5' ends of M vRNA and the 84 central coding region of PB1 vRNA are involved in interactions and co-85 packaging with NA vRNA, respectively. In addition, interactions between 86 PB1 and NS vRNAs may also be necessary for efficient viral replication and 87 genome packaging. However, the region in NS vRNA identified to interact 88 with PB1 vRNA is not located in the region of the previously reported 89 8 genome packaging signal [26] . Thus, the role of vRNA-vRNA interactions in 90 genome packaging remains unclear. 91
In this study, we used serial passaging to identify which vRNA(s) 92 interact with the hemagglutinin (HA) vRNA packaging signal in selective 93 genome packaging. We first generated a mutant influenza virus (A/WSN/33) 94 that possesses five silent mutations in the packaging signal of HA vRNA, 95 which causes a specific defect in the incorporation of HA vRNA. Then, we 96 serially passaged the mutant virus in cultured cells to restore efficient 97 incorporation of HA vRNA, and identified mutations that had been newly 98 introduced into the vRNAs. In addition, we examined the interactions of HA 99 vRNA with potential partner vRNAs in vitro, and assessed the importance 100 of these vRNA-vRNA interactions in the packaging signal regions specific 101 for HA vRNA incorporation and viral replication. 102 103 Generation of mutant viruses possessing silent mutations in the 105 packaging signal of HA vRNA. 106
We first disrupted the packaging signal sequence of HA vRNA which 107 potentially interacts with other vRNAs during selective genome packaging. 108
For this, we used reverse genetics to generate a series of mutant viruses 109 that possessed five silent mutations in either the 3' or 5' packaging signal 110 region of HA vRNA without any amino acid mutations ( Fig 1A) . The 111 respective viral titers were examined by plaque assays (Fig 1B) . Eight out 112 of nine mutant viruses replicated at a level similar to that of the wild-type 113 virus, showing titers of approximately 3.8×10 8 PFU/ml; however, an HA 5m2 114 virus, possessing five silent mutations at nucleotides 1664 to 1676 in HA 115 vRNA, exhibited an approximately 87% reduced growth rate compared to 116 the wild-type virus. Sequence analysis confirmed that no unexpected 117 mutations occurred in any of the eight vRNAs of the HA 5m2 virus. These 118 results indicate that nucleotides 1664 to 1674 in the packaging signal region 119 of HA vRNA are necessary for efficient virus growth and are likely involved 120 10 in HA vRNA packaging, which in agreement with results reported by a 121 previous study [14] . 122 123
Serial passaging of the HA 5m2 virus in cells 124
We hypothesized that after several passages, the HA 5m2 virus 125 would acquire adaptive mutations in vRNAs, which would restore viral 126 fitness. Accordingly, the HA 5m2 virus was serially passaged in Madin-127 Darby Canine Kidney (MDCK) cells, and viral titers were assessed by 128 plaque assay after each passage. The viruses were designated as HA 5m2 129 P1, P2, P3, P4, P5, P6, P7, P8, P9, and P10 viruses, according to the 130 number of passages in MDCK cells. As expected, the growth of the HA 5m2 131 P10 virus was restored to approximately 61% of that shown by the wild-type 132 virus (Fig 2A) . The titer of the HA 5m2 P10 virus did not increase with an 133 additional 10 passages (data not shown). Sequencing analysis of all eight 134 HA 5m2 P10 virus vRNAs revealed that two mutations were newly 135 introduced into the 5' terminal coding regions of HA vRNA (T1665C) and 136 PB2 vRNA (G2271T); both of these vRNAs are located within the previously 137 11 identified genome packaging signaling regions [6, 8, 14, 16] . 138
To assess whether these two mutations contributed to the growth of 139 the HA 5m2 virus, we used reverse genetics to generate recombinant HA 140 5m2 viruses with additional mutation(s). Recombinant HA 5m2 viruses, 141 which possessed a single mutation in HA T1665C or PB2 G2271T, both 142 showed replication that was partially restored to 11 and 24% of the wild-143 type virus, respectively ( Fig 2B) . The recombinant HA 5m2 virus with a 144 double mutation showed replication that was approximately 65% of the wild-145 type virus, similar to the replication levels of the HA 5m2 P10 virus (Fig 2A  146 and 2B). 147
The HA T1665C and PB2 G2271T mutations lead to amino acid 148 substitutions HA S545P and PB2 Q748H, respectively. The amino acid 545 149 is located in the transmembrane region of the HA protein; hence, this 150 substitution may affect intracellular transport to the plasma membrane and 151 subsequent incorporation of HA proteins into progeny virions. Therefore, we 152 examined the amount of HA protein incorporated into progeny virions. 153
Western blotting showed that the amounts of HA protein were comparable 154 in the HA 5m2 P10, HA 5m2 P1, and wild-type virions. This suggests that 155 the S545P substitution has little or no effect on the amount of HA protein 156 incorporated into virions ( Fig 2C) . To examine the impact of the Q748H 157 substitution on the polymerase activity of the PB2 protein, we used RT-158 qPCR to quantify the amount of vRNA in virus-infected cells at 7 hours post-159 infection. The amount of vRNA was similar in HA 5m2 P10-infected, HA 5m2 160 P1-infected, and wild-type virus-infected cells, suggesting that the Q748H 161 substitution in PB2 had little or no effect on polymerase activity ( Fig 2D) . 162
Taken together, these results suggest that T1665C mutations in HA vRNA 163 and G2271T mutations in PB2 vRNA participate in the restoration of HA 5m2 164 viral replication at the RNA level. 165 166
Efficiency of packaging eight vRNAs in HA 5m2 viruses 167
Because the HA 5m2 virus possessed five silent mutations in the 5' 168 packaging signal region of HA vRNA, we predicted that it would show 169 defects in the packaging efficiency of vRNAs (especially of HA vRNA). We 170 also expected that additional mutations in the 5' packaging signals of HA 171 assess the packaging efficiency of the HA 5m2 P1 and HA 5m2 P10 viruses, 173 we extracted vRNA from wild-type, HA 5m2 P1, and HA 5m2 P10 viruses; 174 then, we quantified the amount of the eight influenza vRNA segments using 175 RT-qPCR. As expected, the HA 5m2 P1 virus showed a marked defect in 176 the packaging efficiency of HA vRNA; the packaging efficiency was reduced 177 to approximately 24% compared with that of the wild-type virus. The HA 5m2 178 P1 virus also showed small defects in the packaging efficiency of PA, NP, 179 and NA vRNAs ( Fig 3A) . Importantly, in the HA 5m2 P10 virus, the packaging 180 efficiency of HA vRNA was largely recovered to approximately 72% of that 181 in the wild-type, and those of PA, NP, and NA vRNAs were also partially 182 recovered ( Fig 3A) . 183
To further examine the contribution of the PB2 G2271T and HA 184 T1665C mutations to vRNA packaging efficiency, we used RT-qPCR to 185 analyze the amount of packaged vRNA in recombinant HA 5m2 viruses 186 possessing a single mutation or a double mutation. In both recombinant HA 187 5m2 viruses with either a single PB2 G2271T or HA T1665C mutation, the 188 14 packaging efficiency of HA vRNA was restored to approximately 33 and 59% 189 to that of the wild-type virus, respectively ( Fig 3B) . To examine the incorporation of RNPs into virions in more detail, 214
we determined the proportion of empty particles in wild-type, HA 5m2 P1, 215 and HA 5m2 P10 viruses. For this, virions were purified by 216 ultracentrifugation through a sucrose cushion and observed by cryo-TEM 217 ( Fig 4B) . The particles of the wild-type virus mainly showed uniformly 218 spherical shapes of approximately 111 nm in diameter; 0.9% (n=1085) of 219 virions appeared empty or contained only a few vRNPs (Table 1) We next aimed to confirm that a functional interaction between the 236 5' terminal regions of HA and PB2 vRNAs is involved in efficient packaging 237 of HA vRNA. For this, we used a gel shift assay to examine whether direct 238 RNA-RNA interactions between these two vRNAs occur in vitro. To eliminate 239 possible nonspecific interactions via the non-packaging signal regions of 240 vRNAs, we synthesized a short HA vRNA comprising the 5' noncoding 241 region and the 120-nucleotide long coding region, which is designated as 242 5'HA(120). We also synthesized a short PB2 vRNA comprising the 5' 243 noncoding region and the 300-nucleotide long coding region, which is 244 designated as 5'PB2(300) ( Fig 5A) . In addition to the 5'HA(120) possessing 245 the wild-type HA vRNA sequence, we synthesized mutant 5'HA(120) 246 sequences into which we introduced five silent mutations corresponding to 247 HA 5m1, HA 5m2, HA 5m3, HA 5m4, and HA 5m5 ( Fig 1A) ; these mutant 248 5'HA(120) vRNAs were designated as 5'HA(120) 5m1, 5'HA(120) 5m2, 249 5'HA(120) 5m3, 5'HA(120) 5m4, and 5'HA(120) 5m5, respectively. The 250 18 mixture of wild-type 5'HA(120) and 5'PB2(300) showed slower migration of 251 the band, indicating formation of a vRNA-vRNA complex (Figs 5B and 5C). 252
The mutant 5'HA(120) 5m1, 5'HA(120) 5m3, 5'HA(120) 5m4, and 5'HA(120) 253 5m5 vRNAs also formed a complex with 5'PB2(300), whose proportions 254 were 69-95% compared to the complex of 5'HA(120) and 5'PB2(300). These 255 results are consistent with our viral replication data, showing that such 256 mutations in HA vRNA did not markedly affect viral growth ( Fig 1B) . In 257 contrast, the 5'HA(120) 5m2 vRNA associated with 5'PB2(300) to a lesser 258 degree and did not form a vRNA-vRNA complex efficiently, with only 12% 259 complex formation compared to the 5'HA(120) and 5'PB2(300), correlating 260 with the reduced viral growth of the HA 5m2 virus ( Fig 1B) . Taken together, 261 these results indicate that there is an interaction between the 5' packaging 262 signals of HA and PB2 vRNAs in the context of vRNPs, which is important 263 for optimal packaging of HA vRNA. The 5' packaging signal sequence, located at nucleotides 1662 to 281 1681 in HA vRNA, is more than 90% conserved in H1 subtype influenza 282 20 viruses. However, the neighboring regions show less sequence 283 conservation [14] , suggesting that this region is important for HA vRNA 284 packaging at the RNA level. Our results show that introduction of five silent 285 mutations into the highly conserved region at nucleotides 1664 to 1676 in 286 HA vRNA reduced the incorporation efficiency of HA vRNA ( Fig. 2A ). An 287 additional mutation at nucleotide 1665 restored the reduced efficiency of 288 HA vRNA packaging (Fig. 2B ). This confirms that the highly conserved 289 region in the sequence of the 5' terminal packaging signal is involved in 290 incorporation of HA vRNA. Recent findings indicate that NP non-uniformly 291 decorates vRNA [1, 2]. Therefore, it is possible that the region at 292 nucleotides 1664 to 1676 in HA vRNA, identified in this study, is NP-free 293 and forms secondary or tertiary structures on vRNPs to interact with the 5' 294 packaging signal of PB2 vRNA. However, whether the 5' terminal coding 295 region of HA vRNA is a low NP-binding region remains unclear [1, 2] . 296
Additional work is necessary to determine the precise location of the NP-297 free region of HA vRNA in the A/WSN/33 strain. 298
After the HA 5m2 virus was serially passaged in MDCK cells, the 299 21 virus acquired a G2271T mutation in the 5' packaging signal sequence of 300 PB2 vRNA, which recovered the reduced incorporation of HA vRNA (Fig.  301   2B) . This finding suggests that the region around nucleotide 2271 in PB2 302 vRNA is involved in interactions with HA vRNA. However, a previous study 303 showed that the introduction of silent mutations at nucleotides 2268 to 2286, 304 including a mutation at nucleotide 2271, in PB2 vRNA did not reduce the 305 packaging efficiency of HA vRNA [14] . Therefore, it is possible that the 306 mutation at G2271T in PB2 vRNA, found in this study, was acquired for the 307 optimal packaging of HA 5m2 vRNA but not of wild-type HA vRNA. The reduced HA vRNA packaging efficiency of the HA 5m2 virus was 323 rescued when the virus spontaneously acquired adaptive mutations in HA 324 and PB2 vRNAs during serial passaging ( Fig. 2A and 2B) . primers used are listed in S1 Table. For each sample, reactions contained 408 1 μl 10-fold diluted RT product, 7.5 μl THUNDERBIRD SYBR qPCR Mix 409 (Toyobo), 0.25 μM segment-specific primers, for a final volume of 15 μl. 410 Cycling conditions were: 2 min at 94°C, followed by 40 cycles (98°C for 10 411 s, 55°C for 15 s, and 72°C for 30 s). 412
In Figure 2D , total RNA was extracted from virus-infected cells 413 28 using an RNeasy Mini Kit (Qiagen). For PB2, PB1, HA, and NP vRNAs, RT-414 qPCR was performed as described above, using 100 ng total RNA. The 415 values were expressed as numbers of RNA copies in an infected cell, 416 assuming that a cell contained 10 pg of RNA [29, 30] . 417 418
Ultrathin section electron microscopy (EM) 419
Ultrathin section EM was performed as described previously [3] . Shortened HA and PB2 vRNAs were synthesized in vitro using T7 436 transcription as described previously [30] . Briefly, templates containing a 437 T7 phage promoter sequence (5'-TAATACGACTCACTATAGGG-3') were 438 amplified by PCR using corresponding primer pairs and were purified with 439 a QIAquick PCR purification kit (Qiagen). The primers used are listed in S1 440 Table. Purified PCR products were transcribed in vitro using the RiboMAX 441 
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